Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Propanc Biopharma, Inc. Director's Dealing 2012

Aug 6, 2012

34906_dirs_2012-08-06_6fe0c96a-3263-40d2-aec5-9424d8721b04.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2012-07-16

Reporting Person: Kenyon Julian Norman (Director, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Shares in Propanc Health Group Corp. 2703016 Direct